ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Mayrim V. Rios Perez
Matched on ORCID iD 0000-0001-5584-1315; OpenAlex author ID A5008087370. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 48
2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers
Papers 13
- Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarci… Co-author DOI 10.1038/s41418-024-01387-2↗
- Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-1527↗
- CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Co-author DOI 10.1016/j.molmet.2021.101426↗
- CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. Co-author DOI 10.1200/po.19.00330↗
- Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models. Co-author DOI 10.1016/j.sopen.2019.05.004↗
- Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. First author DOI 10.1021/acs.jproteome.9b00132↗
- Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41418-018-0207-3↗
- A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-17-3668↗
- Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth. Co-author DOI 10.1038/onc.2017.125↗
- Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarci… Co-author DOI 10.1158/1535-7163.mct-16-0526↗
- Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Co-author DOI 10.1158/1078-0432.ccr-15-2780↗
- Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-15-2936↗
- Regression of Stage IV Pancreatic Cancer to Curative Surgery and Introduction of a Novel Ex-Vivo Chemosensitivity Assay. Co-author DOI 10.7759/cureus.423↗
Closest collaborators
The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jason B. Fleming · 13 shared papers, 2015–2024 · strength 1.26
- Paper Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic D… DOI 10.1158/1078-0432.ccr-24-1527↗
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Ya’an Kang · 12 shared papers, 2016–2024 · strength 1.20
- Paper Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic D… DOI 10.1158/1078-0432.ccr-24-1527↗
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Xinqun Li · 7 shared papers, 2016–2024 · strength 0.81
- Paper Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic D… DOI 10.1158/1078-0432.ccr-24-1527↗
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- David Roife · 8 shared papers, 2016–2024 · strength 0.77
- Paper Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic D… DOI 10.1158/1078-0432.ccr-24-1527↗
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models. DOI 10.1016/j.sopen.2019.05.004↗
- Bingbing Dai · 8 shared papers, 2015–2024 · strength 0.73
- Paper Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic D… DOI 10.1158/1078-0432.ccr-24-1527↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models. DOI 10.1016/j.sopen.2019.05.004↗
- Eugene Jon Koay · 7 shared papers, 2015–2024 · strength 0.61
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreati… DOI 10.1021/acs.jproteome.9b00132↗
- Michael P. Kim · 4 shared papers, 2018–2024 · strength 0.43
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreati… DOI 10.1021/acs.jproteome.9b00132↗
- Yeon‐Ju Lee · 4 shared papers, 2016–2024 · strength 0.40
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Rolf A. Brekken · 3 shared papers, 2017–2024 · strength 0.37
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting … DOI 10.1158/1535-7163.mct-16-0526↗
- Anirban Maitra · 4 shared papers, 2018–2022 · strength 0.32
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreati… DOI 10.1021/acs.jproteome.9b00132↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Matthew H. G. Katz · 4 shared papers, 2016–2022 · strength 0.29
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Huamin Wang · 4 shared papers, 2016–2022 · strength 0.29
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paul J. Chiao · 3 shared papers, 2016–2022 · strength 0.24
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Paper Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocar… DOI 10.1158/1078-0432.ccr-15-2780↗
- Michela Capello · 2 shared papers, 2020–2022 · strength 0.19
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Ehsan Irajizad · 2 shared papers, 2020–2022 · strength 0.19
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Jody V. Vykoukal · 2 shared papers, 2020–2022 · strength 0.19
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Laura R. Prakash · 2 shared papers, 2020–2022 · strength 0.19
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Johannes Francois Fahrmann · 2 shared papers, 2020–2022 · strength 0.19
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Samir Hanash · 2 shared papers, 2020–2022 · strength 0.19
- Paper CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent … DOI 10.1016/j.molmet.2021.101426↗
- Paper CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diab… DOI 10.1200/po.19.00330↗
- Robert A. Wolff · 2 shared papers, 2015–2018 · strength 0.12
- Paper Regression of Stage IV Pancreatic Cancer to Curative Surgery and Introduction of a Novel Ex-Vivo Chemosensitivity Assay. DOI 10.7759/cureus.423↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Yihui Chen · 1 shared paper, 2022 · strength 0.12
- Deyali Chatterjee · 2 shared papers, 2016–2018 · strength 0.10
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocar… DOI 10.1158/1078-0432.ccr-15-2780↗
- David R Piwnica-Worms · 1 shared paper, 2019 · strength 0.08
- Subrata Sen · 1 shared paper, 2019 · strength 0.08
- Prasanta Dutta · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.